Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Articles and issues > Author index
Search
Heae Surng Park 2 Articles
The Prognostic Implications of Cystic Change in Clear Cell Renal Cell Carcinoma.
Heae Surng Park, Eun Jung Jung, Jae Kyung Myung, Kyung Chul Moon
Korean J Pathol. 2010;44(2):149-154.
DOI: https://doi.org/10.4132/KoreanJPathol.2010.44.2.149
  • 4,763 View
  • 75 Download
  • 4 Crossref
AbstractAbstract PDF
BACKGROUND
Cystic renal cell carcinoma has been reported to have a good prognosis. However, previous studies included cases of multilocular cystic renal cell carcinoma, which has an excellent prognosis, and renal cell carcinoma with cystic necrosis, which has an adverse prognosis. Therefore, we analyzed the prognostic influence of cystic change in clear cell renal cell carcinoma after excluding those morphological features.
METHODS
We identified 225 patients with clear cell renal cell carcinoma who underwent nephrectomy between 2001 and 2003. The clinicopathologic features were compared with clinical outcomes.
RESULTS
Cystic change in clear cell renal cell carcinoma (n = 66) was significantly associated with younger patient age (< 55), smaller tumor size (< or = 4 cm), lower pT stage (pT1, T2), M0 stage at initial diagnosis, lower tumor, node, and metastasis stage (I, II), and lower nuclear grade (1, 2). Patients with cystic change in clear cell renal cell carcinoma had significantly longer cancer-specific (p = 0.015) and progression-free survival (p = 0.004) than those without cystic change, by univariate analysis. Multivariate analysis revealed that cystic change significantly decreased the risk of cancer progression (risk ratio, 0.27; 95% confidence interval, 0.11 to 0.69).
CONCLUSIONS
In patients with clear cell renal cell carcinoma, cystic change is a good independent predictor for survival.

Citations

Citations to this article as recorded by  
  • Update on MRI of Cystic Renal Masses Including Bosniak Version 2019
    Satheesh Krishna, Nicola Schieda, Ivan Pedrosa, Nicole Hindman, Ronaldo H. Baroni, Stuart G. Silverman, Matthew S. Davenport
    Journal of Magnetic Resonance Imaging.2021; 54(2): 341.     CrossRef
  • Klotho plays a critical role in clear cell renal cell carcinoma progression and clinical outcome
    Ji-Hee Kim, Kyu-Hee Hwang, Sayamaa Lkhagvadorj, Jae Hung Jung, Hyun Chul Chung, Kyu-Sang Park, In Deok Kong, Minseob Eom, Seung-Kuy Cha
    The Korean Journal of Physiology & Pharmacology.2016; 20(3): 297.     CrossRef
  • Insulin Receptor Expression in Clear Cell Renal Cell Carcinoma and Its Relation to Prognosis
    Sayamaa Lkhagvadorj, Sung Soo Oh, Mi-Ra Lee, Jae Hung Jung, Hyun Chul Chung, Seung-Kuy Cha, Minseob Eom
    Yonsei Medical Journal.2014; 55(4): 861.     CrossRef
  • Determination of the Cutoff Value of the Proportion of Cystic Change for Prognostic Stratification of Clear Cell Renal Cell Carcinoma
    Heae Surng Park, Kyoungbun Lee, Kyung Chul Moon
    Journal of Urology.2011; 186(2): 423.     CrossRef
CD44 and MMP14 Expression Associated with WHO Grade of the Astrocytoma and the Prognostic Implications.
Jaekyung Myung, Bogun Jang, Heae Surng Park, Woongjae Yon, Hyun Ju Lee, Sung Hye Park
Korean J Pathol. 2010;44(1):35-41.
DOI: https://doi.org/10.4132/KoreanJPathol.2010.44.1.35
  • 2,873 View
  • 24 Download
AbstractAbstract PDF
BACKGROUND
CD44 is a cell surface receptor that has been implicated in tumor cell invasion and metastasis in a range of tumors of various organs, including breast, ovary, colon, lung, and brain. CD44 stimulates the invasive ability by interacting with matrix metalloproteinase 14 (MMP14). The expression of MMP14 on the cell surface is thought to trigger multiple proteinase cascades and to stimulate cell migration.
METHODS
A total 54 astrocytoma patients were eligible for this study. We performed a retrospective clinicopathological review and CD44 and MMP14 immunohistochemistry.
RESULTS
The expressions of CD44 and MMP14 were significantly correlated with the World Health Organization (WHO) grade. On univariate analysis, the WHO grade and the expression of CD44 were the significant prognostic factors affecting overall survival (OS) and disease progression free survival (DPFS). On the multivariate analysis by the Cox regression model, the only WHO grade was shown to be a significant independent prognostic factor for predicting the DPFS and OS.
CONCLUSIONS
In this study, the CD44 and MMP14 expressions were related to the WHO grade of astrocytoma. The CD44 expression status was a prognostic factor for DPFS and OS on univariate analysis, but it was not an independent prognostic factor on the multivariate analysis.

J Pathol Transl Med : Journal of Pathology and Translational Medicine